Liver Disease
From the Journals
New guide for acute liver failure urges early treatment, transplant referral
The clinical guidelines focus on the diagnosis and management of patients with acute liver failure.
From the Journals
Bulevirtide shows promise in chronic hepatitis D
There is no approved treatment for a hepatitis D virus infection which affects between 10 and 20 million people worldwide.
From the Journals
Two-pronged approach needed in alcohol-associated hepatitis
Patients are likely to carry a dual diagnosis of liver disease and alcohol use disorder.
In Focus
Navigating NAFLD: Unveiling the approach to mitigate the impact of NAFLD
According to the Centers for Disease Control and Prevention, there have been substantial increases in liver-related deaths over the last two...
Latest News
Naltrexone is safe and beneficial in AUD with cirrhosis
VIENNA –
Pearls from the Pros
Incidental hepatic steatosis
It is important to identify patients at risk of progressive fibrosis.
From the Journals
Liver disease gets new name and diagnostic criteria
Formerly known as nonalcoholic fatty liver disease, the condition will now be known as metabolic dysfunction–associated steatotic liver disease (...
Conference Coverage
Breakthroughs and challenges in hepatology
“I have witnessed some of the miracles in modern medicine. However, there remain many challenges.’
Latest News
FDA rejects NASH drug for the second time
Intercept first sought FDA approval for OCA in 2019. The company will discontinue all NASH-related investment.
Latest News
‘Exciting time for NASH’ with resmetirom phase 3 results
Two doses of resmetirom met the primary endpoints of NASH resolution and no worsening of fibrosis on liver biopsy.